Rezolute, Inc. — Director's Dealing 2017

Jan 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2016-10-31

Reporting Person: Elam Nevan C (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-31	Stock Option (right to buy)	$1.2	A	3500000	Acquired	2026-10-31	Common Stock (3500000)	Direct

Footnotes

F1: On October 31, 2016, the Reporting Person was granted 9,500,000 shares of common stock. Pursuant to Board approval and a Refresh Option Agreement, the number of shares was reduced for no consideration on December 27, 2016. An additional 3,600,000 shares may be issued upon certain performance only criteria.

F2: The option vests in forty-eight equal installments beginning on the date so indicated and every month thereafter, such grant vested in full at 4 years.